For examples, in addition to PIK3CA mutations, gene expression signature involved in the PI3K pathway activity may have utility in the identification of breast cancer patients likely to benefit from a selective PI3K inhibitor therapy [22]. The gene discussed is PIK3CA; the disease is breast carcinoma.